These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16095153)

  • 1. [Tissue factor and tissue factor pathway inhibitor during specific bronchial challenge in allergic asthma patients].
    Kemona-Chetnik I; Bodzenta-Lukaszyk A; Kucharewicz I; Rogalewska AM
    Przegl Lek; 2005; 62(2):98-101. PubMed ID: 16095153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombin activatable fibrinolysis inhibitor (TAFI) in allergic asthma patients].
    Kemona-Chetnik I; Kowal K; Kucharewicz I; Pampuch A; Bodzenta-Lukaszyk A
    Przegl Lek; 2006; 63(12):1281-5. PubMed ID: 17642140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus.
    Kowal K; Pampuch A; Kowal-Bielecka O; DuBuske LM; Bodzenta-Łukaszyk A
    Clin Exp Allergy; 2006 Apr; 36(4):426-32. PubMed ID: 16630146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of allergen-induced asthma and associated increase in bronchial responsiveness to methacholine in asthmatic children.
    Cavigioli G; Mastropasqua B; Pelucchi A; Marazzini L; Foresi A
    Ann Allergy; 1993 May; 70(5):411-7. PubMed ID: 8498734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction.
    Schaafsma D; Bos IS; Zuidhof AB; Zaagsma J; Meurs H
    Respir Res; 2006 Sep; 7(1):121. PubMed ID: 17002806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions.
    Korn S; Beier J; Heilmann C; Kornmann O; Buhl R; Michael Beeh K
    Respir Med; 2005 Dec; 99(12):1595-9. PubMed ID: 16291080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the inhaled glucocorticosteroid effects on non specific bronchial reactivity with particular reference to the late inflammatory phase in atopic asthma patients. II. The effect of regular administration of budesonide R on specific and non-specific bronchial reactivity].
    Siergiejko Z; Chyrek-Borowska S; Rogalewska A; Zietkowski Z
    Pol Merkur Lekarski; 1998 May; 4(23):250-3. PubMed ID: 9825654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge.
    Ravensberg AJ; Ricciardolo FL; van Schadewijk A; Rabe KF; Sterk PJ; Hiemstra PS; Mauad T
    J Allergy Clin Immunol; 2005 Apr; 115(4):779-85. PubMed ID: 15805998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue factor (TF) and inhibitor (TFPI) concentrations in patients with urinary tract tumors and haematological malignancies].
    Radziwon P; Schenk JF; Mazgajska K; Boczkowska-Radziwon B; Galar M; Kłoczko J; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):308-11. PubMed ID: 12557438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The late asthmatic response to allergen challenge--Part I.
    Pelikan Z; Pelikan-Filipek M
    Ann Allergy; 1986 May; 56(5):414-20. PubMed ID: 3486610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
    Migdalski A; Kotschy M; Jawien A
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
    Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.